Professional role
an Executive Board member and President-Elect of the Society for Research in Psychopathology[1]
SS
He has over 185 publications related to schizophrenia
He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population.
This includes work with both chronic and first episode patients.
Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse.
Reviewed sources document Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse.. Explore attributed publications and research affiliations.
Explore researchan Executive Board member and President-Elect of the Society for Research in Psychopathology[1]
currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment[1]
Director of Research[1]
Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC)[1]
Director of the Division of Schizophrenia Research[1]
former Chair of the American Psychological Association’s Task Force on Serious Mental Illness[1]
Principal Investigator (PI)[1]
Professor of Psychiatry[1]
Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School[1]
Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse.[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
14 source claims · Reviewed Sep 9, 2026
Biographical context: He has over 185 publications related to schizophrenia
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Biographical context: He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population.
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Biographical context: This includes work with both chronic and first episode patients.
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Identity: Steven Silverstein
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: an Executive Board member and President-Elect of the Society for Research in Psychopathology
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: Director of Research
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC)
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: Director of the Division of Schizophrenia Research
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: former Chair of the American Psychological Association’s Task Force on Serious Mental Illness
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: Principal Investigator (PI)
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: Professor of Psychiatry
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Professional role: Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]
Research interests: Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse.
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), and Professor of Psychiatry at Rutgers - Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and an Executive Board member and President-Elect of the Society for Research in Psychopathology. He has over 25 years of experience in treating people with schizophrenia, and has directed inpatient units and outpatient programs for this population. This includes work with both chronic and first episode patients. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 185 publications related to schizophrenia, and is currently Principal Investigator (PI) on multiple NIMH and foundation grants involving assessment and treatment. E-mail: [contact withheld]